Evidence mapPaperPMID 41366805Full record

ArticleFungal biology and biotechnology2025

Immunogold labeling of extracellular vesicles from the fungal pathogen Fusarium graminearum reveals the presence of the protein marker Sur7.

Donovan Garcia-Ceron, Sarah M Wilson, Mark R Bleackley, Marilyn A Anderson

Abstract read
In one paragraph

Article in Fungal biology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Donovan Garcia-CeronDepartment of Ecological, Plant, and Animal Sciences, La Trobe University, Bundoora, Australia. d.garcia-ceron@latrobe.edu.au.
Sarah M WilsonLa Trobe Bioimaging Platform, La Trobe University, Bundoora, Australia.
Mark R BleackleyDepartment of Biochemistry and Chemistry, La Trobe University, Bundoora, Australia.
Marilyn A AndersonDepartment of Biochemistry and Chemistry, La Trobe University, Bundoora, Australia.

Funding

Australian Research Council DP160100309Australian Research Council IH190100022La Trobe University ABC grant
6 · The paper itself

Abstract

Fusarium head blight, caused by Fusarium graminearum, is one of the most threatening fungal diseases of cereals worldwide. Current practices for control of F. graminearum are not always efficient, as epidemics still occur and there is low resistance in wheat varieties. Therefore, novel antifungal targets must be discovered by analyzing the molecular interaction between F. graminearum and its host. Fungal extracellular vesicles (EVs) are small membrane-bound compartments (30-1000 nm) that carry macromolecules and support fungal virulence, hence the disruption of EV production could lead to reduced fungal pathogenicity. However, EV study is limited by the lack of surface protein markers to aid in their characterization. Therefore, the aim of this report was to target a surface protein marker with an antibody, to unlock advanced EV characterization techniques. Using the list of potential EV markers for Candida albicans, we selected the tetraspanin-like Sur7 to perform immunogold microscopy, revealing that this protein is a surface marker of F. graminearum EVs. SUR7 is present on the surface of some but not all vesicles. EVs carrying SUR7 were larger than those without the marker, suggesting that there are subtypes of fungal EVs. The epitope recognized by the anti-Sur7 antibody is conserved in other Fusarium pathogens, making Sur7 a potential pan-Fusarium EV marker. Our results unlock techniques, such as immunoaffinity chromatography and antibody labeling, to track fungal EVs and understand their biogenesis, which may lead to the development of novel antifungals.

Indexed as

Cross-kingdom communicationEV surface markerFusarium graminearumHead blightImmunogold labelingPlant pathologyProteomicsTetraspanin

Identifiers

PMID41366805
PMCPMC12801696

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.